These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10611644)

  • 1. Characterization of the sequential non-covalent and covalent interactions of the antitumour antibiotic hedamycin with double stranded DNA by NMR spectroscopy.
    Pavlopoulos S; Bicknell W; Wickham G; Craik DJ
    J Mol Recognit; 1999; 12(6):346-54. PubMed ID: 10611644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural characterization of the 1:1 adduct formed between the antitumor antibiotic hedamycin and the oligonucleotide duplex d(CACGTG)2 by 2D NMR spectroscopy.
    Pavlopoulos S; Bicknell W; Craik DJ; Wickham G
    Biochemistry; 1996 Jul; 35(29):9314-24. PubMed ID: 8755709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hedamycin intercalates the DNA helix and, through carbohydrate-mediated recognition in the minor groove, directs N7-alkylation of guanine in the major groove in a sequence-specific manner.
    Hansen M; Yun S; Hurley L
    Chem Biol; 1995 Apr; 2(4):229-40. PubMed ID: 9383425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The observation of a hedamycin-d(CACGTG)2 covalent adduct by electrospray mass spectrometry.
    Wickham G; Iannitti P; Boschenok J; Sheil MM
    FEBS Lett; 1995 Mar; 360(3):231-4. PubMed ID: 7883038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural investigation of the hedamycin:d(ACCGGT)2 complex by NMR and restrained molecular dynamics.
    Owen EA; Burley GA; Carver JA; Wickham G; Keniry MA
    Biochem Biophys Res Commun; 2002 Feb; 290(5):1602-8. PubMed ID: 11820806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solution structure of the esperamicin A1-DNA complex.
    Kumar RA; Ikemoto N; Patel DJ
    J Mol Biol; 1997 Jan; 265(2):173-86. PubMed ID: 9020981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of the altromycin B (N7-guanine)-DNA adduct. A proposed prototypic DNA adduct structure for the pluramycin antitumor antibiotics.
    Sun D; Hansen M; Clement JJ; Hurley LH
    Biochemistry; 1993 Aug; 32(32):8068-74. PubMed ID: 8347608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the sequence selectivity of the DNA-alkylating pluramycin antitumour antibiotics DC92-B and hedamycin.
    Prakash AS; Moore AG; Murray V; Matias C; McFadyen WD; Wickham G
    Chem Biol Interact; 1995 Mar; 95(1-2):17-28. PubMed ID: 7697748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural modification changes the DNA binding mode of cation-substituted anthraquinone photonucleases: association by intercalation or minor groove binding determines the DNA cleavage efficiency.
    Breslin DT; Yu C; Ly D; Schuster GB
    Biochemistry; 1997 Aug; 36(34):10463-73. PubMed ID: 9265626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solution structure of the calicheamicin gamma 1I-DNA complex.
    Kumar RA; Ikemoto N; Patel DJ
    J Mol Biol; 1997 Jan; 265(2):187-201. PubMed ID: 9020982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solution structure of a quinomycin bisintercalator-DNA complex.
    Chen H; Patel DJ
    J Mol Biol; 1995 Feb; 246(1):164-79. PubMed ID: 7853395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The photodeactivation of hedamycin, an antitumor antibiotic of the pluramycin type.
    Fredenhagen A; Séquin U
    J Antibiot (Tokyo); 1985 Feb; 38(2):236-41. PubMed ID: 3997668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 31P NMR study of daunorubicin-d(CGTACG) complex in solution. Evidence of the intercalation sites.
    Ragg E; Mondelli R; Battistini C; Garbesi A; Colonna FP
    FEBS Lett; 1988 Aug; 236(1):231-4. PubMed ID: 3402614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structural basis for in situ activation of DNA alkylation by duocarmycin SA.
    Smith JA; Bifulco G; Case DA; Boger DL; Gomez-Paloma L; Chazin WJ
    J Mol Biol; 2000 Jul; 300(5):1195-204. PubMed ID: 10903864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanics and molecular dynamics studies of the intercalation of dynemicin-A with oligonucleotide models of DNA.
    Cardozo MG; Hopfinger AJ
    Mol Pharmacol; 1991 Dec; 40(6):1023-8. PubMed ID: 1758437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of the antitumor drug nogalamycin to bulged DNA structures.
    Caceres-Cortes J; Wang AH
    Biochemistry; 1996 Jan; 35(2):616-25. PubMed ID: 8555235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel antitumor antibiotics, saptomycins. II. Isolation, physico-chemical properties and structure elucidation.
    Abe N; Enoki N; Nakakita Y; Uchida H; Nakamura T; Munekata M
    J Antibiot (Tokyo); 1993 Oct; 46(10):1536-49. PubMed ID: 8244881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential DNA recognition by the enantiomers of 1-Rh(MGP)2 phi: a combination of shape selection and direct readout.
    Franklin SJ; Barton JK
    Biochemistry; 1998 Nov; 37(46):16093-105. PubMed ID: 9819202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interaction of nemorubicin metabolite PNU-159682 with DNA fragments d(CGTACG)(2), d(CGATCG)(2) and d(CGCGCG)(2) shows a strong but reversible binding to G:C base pairs.
    Mazzini S; Scaglioni L; Mondelli R; Caruso M; Sirtori FR
    Bioorg Med Chem; 2012 Dec; 20(24):6979-88. PubMed ID: 23154079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solution structures of C-1027 apoprotein and its complex with the aromatized chromophore.
    Tanaka T; Fukuda-Ishisaka S; Hirama M; Otani T
    J Mol Biol; 2001 May; 309(1):267-83. PubMed ID: 11491295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.